New Concept Workshop

A New Concept Workshop will be held by Breast Cancer Trials (BCT) at the 45th Annual Scientific Meeting (ASM), to provide an opportunity for BCT members and non-members to present new research ideas. The Workshop will be held at the Cairns Convention Centre from 1:30-5pm on Wednesday 24th July 2024.

The workshop will involve a presentation of selected concepts, followed by discussion and feedback from the audience. The audience will include BCT Scientific Advisory Committee members including Consumer Advisory Panel representatives, senior BCT staff, and other BCT researchers. Presenters will be expected to attend the workshop in person (virtual presentation is not being used).

This workshop is designed to be an opportunity for those with ideas with the potential to become BCT-led clinical trials to present them to the group. These ideas can potentially move forward to a more formal stage of concept development with the support of BCT’s Scientific Advisory Committee.

Concepts are welcomed from all disciplines relevant to breast cancer care, including medical, surgical, or radiation oncology, reconstructive surgery, imaging, pathology, and the disciplines involved in supportive care.

Submissions are welcome from both BCT members and non-members. However, for all concepts that are approved for ongoing development, applicants must become BCT members. Please visit our website for information on how to become a member.

Click here for additional information about the BCT trial development process, or visit the ‘Research’ section of the website if you are a full member. Refer to the ‘Clinical Trials/Investigator Resources’ tab or via the following link Research Development and Funding.

Please note: Phase I trials will not generally be considered for conduct and led by BCT unless the science is from the laboratory of a BCT member, drug supply is enabled, and there is a pathway to a Phase II study that will involve BCT.

Eligibility Criteria

  • Fulfils the definition of clinical or translational research that relates to prior, current or the development of future BCT-led breast cancer clinical trials.
  • Potential to make a significant impact on the care of those affected by breast cancer.
  • Feasible as research with significant involvement from BCT.
  • Potentially eligible for competitive funding e.g. NHMRC or Cancer Councils.

Application Process

  • Concept submissions will be peer reviewed and reviews provided to applicants.
  • Up to six concepts will be chosen for presentation, with notification in mid/late June 2024.
  • BCT will invite a discussant for each presentation.
  • A critique will be provided by BCT following concept presentation at the workshop on 24th July 2024.

The closing date for Concept Proposal submissions is Friday 31st May 2024.